| Typically developing control (TDC) n = 38 | Intellectually able ASD (ASD-IA) n = 34 | Intellectually impaired ASD (ASD-II) n = 31 | P value | Post hoc test | |||
---|---|---|---|---|---|---|---|---|
 | Mean | SD | Mean | SD | Mean | SD |  |  |
Sex (M:F) | 30:8 | 30:4 | 29:2 | 0.20a | – | |||
Age (years) | 17.3 | 5.65 | 15.9 | 5.46 | 17.3 | 6.41 | 0.55b | – |
RMS (mm) | 0.399 | 0.197 | 0.407 | 0.184 | 0.463 | 0.216 | 0.40c | – |
Total outliers (%) | 1.28 | 0.69 | 1.48 | 0.72 | 1.63 | 0.95 | 0.15c | – |
Medication (Y:N) | 0:38 | 14:20 | 9:22 | 0.31a | –d | |||
Comorbidity (Y:N) | 0:38 | 26:8 | 24:7 | 0.93a | –d | |||
ICV (cm3) | 1604.7 | 142.1 | 1588.8 | 114.5 | 1626.2 | 104.7 | 0.47b | – |
Cognition and symptoms | ||||||||
FSIQ (WISC/WAIS-IV) | 112.2 | 11.7 | 104.5 | 14.2 | 65.7 | 13.0 |  < 0.001c | ASD-II < ASD-IA, TDC |
NVFIQ (Leiter-R) | 121.6 | 10.2 | 115.0 | 18.3 | 77.6 | 26.3 |  < 0.001c | ASD-II < ASD-IA, TDC |
VABS-ABC | 113.5 | 15.3 | 89.2 | 15.1 | 66.7 | 9.6 |  < 0.001c | ASD-II < ASD-IA < TDC |
BRIEF-GEC | 92.3 | 19.1 | 155.3 | 28.5 | 152.5 | 25.5 |  < 0.001c | ASD-II, ASD-IA > TDC |
SRS-Total | 18.0 | 10.4 | 87.6 | 27.0 | 93.8 | 23.3 |  < 0.001c | ASD-II, ASD-IA > TDC |
ADOS-2 CSS | N/A | N/A | 5.0 | 2.1 | 6.8 | 2.1 | 0.002c | ASD-II > ASD-IAd |